Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?

H. Batura-Gabryel, A. Szczepanik (Poznan, Poland)

Source: Annual Congress 2003 - Markers, mediators and mechanisms of human lung injury
Session: Markers, mediators and mechanisms of human lung injury
Session type: Thematic Poster Session
Number: 623
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Batura-Gabryel, A. Szczepanik (Poznan, Poland). Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?. Eur Respir J 2003; 22: Suppl. 45, 623

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Systemic inflammation, blood eosinophils count and lung function in COPD patients
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Biochemical parameters of sputum and their correlation with inflammation blood markers in AECOPD patients
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


The lung parenchyma in COPD patients: in vitro mechanics and its correlation with inflammatory and structural changes
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007


Relationship of airway structural changes and lung function abnormalities with blood and BAL biomarkers in asthma
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019



Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

The longitudinal relationship between bacterial load airway inflammation and lung function decline in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002

Some local markers indices of saliva inflammation in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 62s
Year: 2004

The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002

Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019




Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD
Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients
Year: 2009


Relationships between inflammatory markers, response to therapy, and lung function decline
Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes
Year: 2017


Associations between blood eosinophils and decline in lung function among adults with and without asthma
Source: Eur Respir J, 51 (4) 1702536; 10.1183/13993003.02536-2017
Year: 2018



COPD patients exhibit abnormally increased peripheral neutrophil stiffening not different from smokers with normal lung function
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009

The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests
Source: Eur Respir J 2002; 20: Suppl. 38, 106s
Year: 2002

Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011


Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017